Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-20

Clinical Trial Update: Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating cyclophosphamide in patients undergoing donor bone marrow transplant for Fanconi anemia has completed. The trial sponsor listed is Fred…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Fanconi Anemia | Phase 1 | Status: COMPLETED